Damage control resuscitation: the need for specific blood products to treat the coagulopathy of trauma
暂无分享,去创建一个
[1] S. Wilson,et al. Improved survival following massive transfusion in patients who have undergone trauma. , 1999, Archives of surgery.
[2] P. Sperryn,et al. Blood. , 1989, British journal of sports medicine.
[3] Jacques Duranteau,et al. Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma , 2005, Critical care.
[4] Mauricio Lynn,et al. Early coagulopathy predicts mortality in trauma. , 2003, The Journal of trauma.
[5] John B Holcomb,et al. Scientific priorities and strategic planning for resuscitation research and life saving therapy following traumatic injury: report of the PULSE Trauma Work Group. , 2002, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[6] A. Sauaia,et al. Predicting life-threatening coagulopathy in the massively transfused trauma patient: hypothermia and acidoses revisited. , 1997, The Journal of trauma.
[7] G. Dickneite,et al. The effect of fibrinogen concentrate administration on coagulation abnormalities in a rat sepsis model , 2004, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[8] T. Haas,et al. Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model. , 2005, British journal of anaesthesia.
[9] J. Hess,et al. Treating coagulopathy in trauma patients. , 2003, Transfusion medicine reviews.
[10] J. Como,et al. Blood transfusion rates in the care of acute trauma , 2004, Transfusion.
[11] M. Rotondo,et al. 'Damage control': an approach for improved survival in exsanguinating penetrating abdominal injury. , 1992, The Journal of trauma.